Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent shares rose 2.8% to $178.06 Friday, rebounding after a 9.6% drop the previous day. The move followed a softer U.S. jobs report that shifted rate expectations and lifted tech stocks. Coherent’s next earnings report is expected in early February, with investors watching U.S. CPI data on Jan. 13. The stock’s price-to-earnings ratio stands at 227.5, well above the industry median.
10 January 2026
··
Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Lululemon shares fell 3.9% Friday, closing at $203.90 after dipping near $200. The drop followed uncertainty over U.S. Supreme Court action on tariffs, with a ruling possible Jan. 14. CEO Calvin McDonald will step down Jan. 31, with two interim co-CEOs named. Founder Chip Wilson has launched a proxy fight, nominating three directors amid pressure from Elliott Management.
10 January 2026
·
Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

The U.S. Supreme Court will hear Cisco’s appeal in a lawsuit alleging it aided China’s crackdown on Falun Gong. Cisco shares fell 0.1% to $73.88 Friday, underperforming a record-setting S&P 500. The case tests whether U.S. firms can face lawsuits at home for alleged human rights abuses abroad. Investors await next week’s inflation data and Cisco’s Feb. 11 earnings call.
10 January 2026
·
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck shares fell 0.4% to $110.53 after reports it is in talks to acquire Revolution Medicines for up to $32 billion. The company faces new scrutiny over its Gardasil and RotaTeq vaccines after U.S. policy changes, with analysts estimating a $2 billion annual revenue impact. Wolfe Research upgraded Merck, citing progress on a subcutaneous version of Keytruda.
10 January 2026
····
BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine Immersion Technologies shares dropped 3.9% to $30.06 Friday after naming Young Kim as CFO and COO and unveiling a pay package with stock awards and bonuses. The moves come ahead of a Jan. 15 shareholder vote on raising the company’s authorized share count. Trading volume reached 37.6 million shares. Investors face a Jan. 14 proxy deadline as debate continues over dilution and compensation.
10 January 2026
NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power shares rose 4.3% to $20.51 in after-hours trading Friday after Bank of America upgraded the stock to neutral with a $28 target, citing funding and timing challenges. Meta’s new nuclear power deals fueled sector-wide gains, with Vistra and Oklo jumping nearly 14%. Options trading in NuScale surged 31% above average. The stock remains below key moving averages ahead of earnings expected March 2.
10 January 2026
····
AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie shares fell 1.8% to $220.08 after the company cut its 2025 earnings forecast and denied takeover talks with Revolution Medicines. AbbVie now expects Q4 adjusted EPS of $2.61–$2.65, down from $3.32–$3.36, and full-year EPS of $9.90–$9.94. The company cited $1.265 billion in R&D and milestone charges. AbbVie said its fourth-quarter results are preliminary.
10 January 2026
···
P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

Procter & Gamble will change Kid’s Crest toothpaste packaging after Texas officials said label artwork encouraged unsafe fluoride use by children. The rollout began Jan. 1 and must last five years. P&G shares closed up 0.24% at $141.87, then slipped 0.17% after hours. Investors await the Jan. 22 earnings call for updates on volumes, pricing, and regulatory scrutiny.
10 January 2026
··
Zillow stock stumbles after Mizuho downgrade flags listing-access fight and Flex legal risk

Zillow stock stumbles after Mizuho downgrade flags listing-access fight and Flex legal risk

Zillow shares fell about 2% Friday after Mizuho downgraded the stock to Neutral and slashed its price target to $70, citing legal risks over home listings and uncertainty around the Flex program. The downgrade comes as a court ruling nears in a Compass lawsuit challenging Zillow’s listing access policy. Rising mortgage rates and new federal bond purchases have added volatility to housing stocks. Analyst targets for Zillow have dropped in recent months.
10 January 2026
··
1 … 254 255 256 257 258 … 608

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
Go toTop